Spaventa Andrew
Singular Genomics Systems, Inc. · Chief Executive Officer
Spaventa Andrew is listed in filings as Chief Executive Officer at Singular Genomics Systems, Inc.. This profile follows SEC Form 4 activity through Feb 25, 2025, including sale activity. Recent filings connect the profile to Singular Genomics Systems, Inc. (OMIC). The current snapshot covers public activity from Jun 18, 2024 to Feb 25, 2025. Reported amounts are shown as $4.8K to $15.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.2k175 shares | SellSep 15, 2024 | $12.38 | $20.01 | |
| $16k695 shares | SellNov 12, 2024 | $22.55 | $20.01 | |
| $3.6k180 shares | SellDec 16, 2024 | $20.16 | $20.01 |